期刊文献+

医院住院患者注射用质子泵抑制剂合理用药分析 被引量:7

Rational Application of Proton Pump Inhibitors for Injection in Inpatients in a Hospital
下载PDF
导出
摘要 目的探讨医院住院患者注射用质子泵抑制剂(PPIs)合理用药情况。方法选取医院2016年1月至12月收治的使用PPIs住院患者375例。采用问卷调查的方式汇总使用情况,并进行综合性评价。结果使用PPIs主要以预防用药为目的260例(69.33%),治疗用药115例(30.67%);单纯静脉给药280例(74.67%),先静脉给药后改为口服给药69例(18.40%);给予PPIs主要为手术病例应激性溃疡169例(45.07%),使用率最低为急性胰腺炎2例(0.53%);遵医嘱进行评价,合理用药223例(59.47%),不合理用药152例(40.53%)。结论医院PPIs普遍用于预防急性胃黏膜病变,部分使用与药品说明书中规定适应证迥异,但目前无滥用、过量使用现象。 Objective To investigate the rational application of proton pump inhibitors(PPIs)for injection in inpatients in a hospital.Methods Totally 375 inpatients underwent the PPIs in our hospital from January to December 2016 were selected and comprehensively analyzed through questionnaire survey.Results The application of PPIs for prevention drug use accounted for 69.33%(260 cases)and treatment drug use accounted for 30.67%(115 cases).Totally 280 cases(74.67%)were only given intravenous administration,69 cases(18.40%)were given oral administration after intravenous administration.The main disease types of inpatients given PPIs were stress ulcer(169 cases,45.07%),and acute pancreatitis was the disease with the lowest PPIs use rate(2 cases,0.53%).The evaluation was carried out according to the doctor’s advice,223 cases(59.47%)were rational drug use and 152 cases(40.53%)were irrational drug use.Conclusion PPIs are mainly used for the prevention of acute gastrointestinal mucosal injury in our hospital.Some application cases are quite different from the indications of the drug instructions,but there is no abuse or overuse at present.
作者 周春燕 何福 李治纲 韩彩平 程果果 ZHOU Chunyan;HE Fu;LI Zhigang;HAN Caiping;CHENG Guoguo(Department of Pharmacy,Kashgar Prefecture Second People's Hospital,Kashgar,Xinjiang,China 844000;Department of Pharmacy,The First People's Hospital cf Kashgar Prefecture,Kashgar,Xinjiang,China 844000)
出处 《中国药业》 CAS 2019年第13期81-83,共3页 China Pharmaceuticals
基金 新疆维吾尔自治区自然科学基金[2018D01C029]
关键词 三级甲等医院 住院患者 质子泵抑制剂 合理用药 grade-A tertiary hospital inpatient proton pump inhibitors rational drug use
  • 相关文献

参考文献8

二级参考文献72

  • 1卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 2李振.恶性肿瘤的化学治疗与免疫治疗[M].北京:人民卫生出版社,1994.63.
  • 3广东省药学会.药品未注册用法专家共识[Z].广东省药学会.20lO.
  • 4Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient [ J 1. Nat Rev Gastroenterol Hepatol, 2015, 12(2) :9$-107.
  • 5Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? [J]. Curr Opin Crit Care, 2009, 15(2) :139-143.
  • 6Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group[J~. N Engl J Med, 1994, 330(6) :377-381.
  • 7Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients [ J ]. J Crit Care, 2005, 20 (1) :35-45.
  • 8ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998 [ J]. Am J Health Syst Pharm, 1999, 56(4) :347-379.
  • 9Spirt M J, Stanley S. Update on stress ulcer prophylaxis in critically ill patients [ J ]. Crit Care Nurse, 2006, 26 ( 1 ) : 18-20, 22 -25.
  • 10Marik PE, Vasu T, Hirani A, et al. Stress ulcer prophylaxis in the new millennium : a systematic review and meta-analysis [ J ]. Crit Care Med, 2010, 38 ( 11 ) :2222-2228.

共引文献301

同被引文献41

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部